Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -710 | -4,085 | -3,286 | -1,986 | -925 |
| Depreciation Amortization | 28 | 146 | 84 | 56 | 28 |
| Accounts receivable | -230 | -91 | -31 | 168 | 155 |
| Other Working Capital | -175 | -194 | -158 | 54 | 67 |
| Other Operating Activity | 278 | 1,605 | 1,411 | 400 | 120 |
| Operating Cash Flow | $-810 | $-2,619 | $-1,979 | $-1,309 | $-555 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7 | 7 | N/A | N/A |
| Purchase Sale Intangibles | -6 | -34 | -20 | -6 | -6 |
| Other Investing Activity | -6 | -34 | -20 | -6 | -6 |
| Investing Cash Flow | $-6 | $-27 | $-13 | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 31 | 29 | N/A | N/A |
| Debt Repayment | -9 | -45 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,668 | 2,715 | 827 | 707 |
| Financing Cash Flow | $-9 | $2,654 | $2,743 | $827 | $707 |
| Beginning Cash Position | 1,294 | 1,285 | 1,285 | 1,285 | 1,285 |
| End Cash Position | 525 | 1,294 | 2,034 | 740 | 1,333 |
| Net Cash Flow | $-768 | $9 | $749 | $-545 | $48 |
| Free Cash Flow | |||||
| Operating Cash Flow | -810 | -2,619 | -1,979 | -1,309 | -555 |
| Free Cash Flow | -810 | -2,619 | -1,979 | -1,309 | -555 |